TRAVIS SVENSSON: Open Payments
NPI 1780619783 · BURLINGAME, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 13 payments from 7 companies in 2025. Trend: 2023 $93 · 2024 $113 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $115 |
| Indivior Inc. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
Products named: INGREZZA, SUBLOCADE, CAPLYTA, FANAPT, COBENFY, Auvelity, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
